Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling

Molecular Cell

Volumn 11, Issue 3, 2003, Pages 695-707

  Reid, George ^a   Hübner, Michael R ^a   Métivier, Raphaël ^a   Brand, Heike ^a   Denger, Stefanie ^a   Manu, Dominique ^a   Beaudouin, Joël ^a   Ellenberg, Jan ^a   Gannon, Frank ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; LIGAND; LIGASE; PROTEOME;

ARTICLE; BLEACHING; CHEMICAL ANALYSIS; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; EVALUATION; GENE ACTIVATION; GENETIC LINKAGE; HEREDITY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KINETICS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0037351881     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00090-X     Document Type: Article

References (47)

1. Alarid E.T., Bakopoulos N., Solodin N. Proteasome-mediated proteolysis of estrogen receptor. a novel component in autologous down-regulation Mol. Endocrinol. 13:1999;1522-1534.
2. Aumais J.P., Lee H.S., Lin R., White J.H. Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation. J. Biol. Chem. 272:1997;12229-12235.
3. Baumeister W., Walz J., Zuhl F., Seemuller E. The proteasome. paradigm of a self-compartmentalizing protease Cell. 92:1998;367-380.
4. Belandia B., Orford R.L., Hurst H.C., Parker M.G. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J. 21:2002;4094-4103.
5. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
6. Burakov D., Crofts L.A., Chang C.P., Freedman L.P. Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J. Biol. Chem. 277:2002;14359-14362.
7. Clawson G.A., Ren L., Isom H.C. Nuclear scaffold-associated protease. in situ nuclear localization and effects of a protease inhibitor on growth and morphology of a ras-transformed hepatocyte cell line Hepatology. 22:1995;1230-1235.
8. Dauvois S., Danielian P.S., White R., Parker M.G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA. 89:1992;4037-4041.
9. De Conto F., Pilotti E., Razin S.V., Ferraglia F., Geraud G., Arcangeletti C., Scherrer K. In mouse myoblasts nuclear prosomes are associated with the nuclear matrix and accumulate preferentially in the perinucleolar areas. J. Cell Sci. 113:2000;2399-2407.
10. Deroo B.J., Rentsch C., Sampath S., Young J., DeFranco D.B., Archer T.K. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22:2002;4113-4123.
11. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis. 17:1996;2279-2284.
12. Fletcher T.M., Xiao N., Mautino G., Baumann C.T., Wolford R., Warren B.S., Hager G.L. ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Mol. Cell. Biol. 22:2002;3255-3263.
13. Freeman B.C., Yamamoto K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science. 296:2002;2232-2235.
14. Gonzalez F., Delahodde A., Kodadek T., Johnston S.A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science. 296:2002;548-550.
15. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., Chambon P. Human oestrogen receptor cDNA. sequence, expression and homology to v-erb-A Nature. 320:1986;134-139.
16. Grossman S.R., Perez M., Kung A.L., Joseph M., Mansur C., Xiao Z.X., Kumar S., Howley P.M., Livingston D.M. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell. 2:1998;405-415.
17. He D.C., Nickerson J.A., Penman S. Core filaments of the nuclear matrix. J. Cell Biol. 110:1990;569-580.
18. Jensen E.V., Suzuki T., Numata M., Smith S., DeSombre E.R. Estrogen-binding substances of target tissues. Steroids. 13:1969;417-427.
19. Kenealy M.R., Flouriot G., Sonntag-Buck V., Dandekar T., Brand H., Gannon F. The 3′-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover. Endocrinology. 141:2000;2805-2813.
20. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
21. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:2002;648-653.
22. Lonard D.M., Nawaz Z., Smith C.L., O'Malley B.W. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol. Cell. 5:2000;939-948.
23. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:1982;7895-7903.
24. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators. multiple enzymes, multiple complexes, multiple functions J. Steroid Biochem. Mol. Biol. 69:1999;3-12.
25. McNally J.G., Muller W.G., Walker D., Wolford R., Hager G.L. The glucocorticoid receptor. rapid exchange with regulatory sites in living cells Science. 287:2000;1262-1265.
26. Métivier R., Stark A., Flouriot G., Hubner M.R., Brand H., Penot G., Manu D., Denger S., Reid G., Kos M.et al. A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell. 10:2002;1019-1032.
27. Mosselman S., Polman J., Dijkema R. ER beta. identification and characterization of a novel human estrogen receptor FEBS Lett. 392:1996;49-53.
28. Nathan D.F., Vos M.H., Lindquist S. In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone. Proc. Natl. Acad. Sci. USA. 94:1997;12949-12956.
29. Nawaz Z., Lonard D.M., Dennis A.P., Smith C.L., O'Malley B.W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA. 96:1999;1858-1862. a.
30. Nawaz Z., Lonard D.M., Smith C.L., Lev-Lehman E., Tsai S.Y., Tsai M.J., O'Malley B.W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1999;1182-1189. b.
31. Nirmala P.B., Thampan R.V. Ubiquitination of the rat uterine estrogen receptor. dependence on estradiol Biochem. Biophys. Res. Commun. 213:1995;24-31.
32. Nuclear Receptor Commitee A unified nomenclature system for the nuclear receptor superfamily. Cell. 97:1999;161-163.
33. Oesterreich S., Zhang Q., Hopp T., Fuqua S.A., Michaelis M., Zhao H.H., Davie J.R., Osborne C.K., Lee A.V. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol. Endocrinol. 14:2000;369-381.
34. Preisler-Mashek M.T., Solodin N., Stark B.L., Tyriver M.K., Alarid E.T. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha. Am. J. Physiol. Endocrinol. Metab. 282:2002;E891-E898.
35. Reid G., Denger S., Kos M., Gannon F. Human estrogen receptor-alpha. regulation by synthesis, modification and degradation Cell. Mol. Life Sci. 59:2002;821-831.
36. Reits E.A., Benham A.M., Plougastel B., Neefjes J., Trowsdale J. Dynamics of proteasome distribution in living cells. EMBO J. 16:1997;6087-6094.
37. Saccani S., Pantano S., Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters. J. Exp. Med. 193:2001;1351-1359.
38. Saji S., Okumura N., Eguchi H., Nakashima S., Suzuki A., Toi M., Nozawa Y., Saji S., Hayashi S. MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem. Biophys. Res. Commun. 281:2001;259-265.
39. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852.
40. Stenoien D.L., Mancini M.G., Patel K., Allegretto E.A., Smith C.L., Mancini M.A. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol. Endocrinol. 14:2000;518-534.
41. Stenoien D.L., Patel K., Mancini M.G., Dutertre M., Smith C.L., O'Malley B.W., Mancini M.A. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat. Cell Biol. 3:2001;15-23.
42. Sun L., Johnston S.A., Kodadek T. Physical association of the APIS complex and general transcription factors. Biochem. Biophys. Res. Commun. 296:2002;991-999.
43. Szak S.T., Mays D., Pietenpol J.A. Kinetics of p53 binding to promoter sites in vivo. Mol. Cell. Biol. 21:2001;3375-3386.
44. Wang C., Fu M., Angeletti R.H., Siconolfi-Baez L., Reutens A.T., Albanese C., Lisanti M.P., Katzenellenbogen B.S., Kato S., Hopp T.et al. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J. Biol. Chem. 276:2001;18375-18383.
45. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway. potential origin for the cell-specific estrogen-like effects of antiestrogens Mol. Endocrinol. 9:1995;443-456.
46. Ylikomi T., Wurtz J.M., Syvala H., Passinen S., Pekki A., Haverinen M., Blauer M., Tuohimaa P., Gronemeyer H. Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity. Crit. Rev. Biochem. Mol. Biol. 33:1998;437-466.
47. Zimmermann H., Degenkolbe R., Bernard H.U., O'Connor M.J. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J. Virol. 73:1999;6209-6219.